Aerocrine: The latest share price. Save Reset. Aerocrine (AERO). kr n/a. % kr Today’s Low & High; n/a / n/a. Open / Previous Close; n/a / Aerocrine AB researches, developes, and sells systems and products for measuring airway inflammation. The Company has developed a method for diagnosing. Aerocrine Ab (GM) historical price data and ACNOY charts. Free real-time prices, trades, and chat.
|Published (Last):||9 July 2011|
|PDF File Size:||5.24 Mb|
|ePub File Size:||7.96 Mb|
|Price:||Free* [*Free Regsitration Required]|
Aerocrine is a medical technology company focused on improving the treatment of patients with inflamed airways. The total value of the Offer, based on , shares in Aerocrine, amounts to SEK 1,, The effect of any such acceleration would be that Aerocrine would be required to pay a prepayments penalty equal to 50 aeeocrine cent of the amount being prepaid.
The Opinion is attached to this statement. Both products enable fast and reliable management of airway inflammation and may therefore play a critical role in more effective diagnosis, treatment and follow-up of patients with inflammatory airway diseases such as asthma. All Stock Pprices Add a Video.
Aerocrine has taken this significant discovery from laboratory to listed company and is now established in some of the worlds largest markets. This means that in case Circassia completes the Offer, even if such completion is made at a lower acceptance level than more than 90 per cent of the shares, the payment under the credit agreement may be accelerated and the prepayment penalty may become due and payable.
The Offer represents a multiple of 8.
This press release may not be published, distributed, transmitted or otherwise sent into the United States of America including its territories and possessions, every State in the United States and the District of ColumbiaAustralia, Canada, Japan or South Africa or any other state or jurisdiction in which such release, publication or distribution would be unlawful.
Best deals amd access real time data!
Statement by the Board of Directors of Aerocrine in relation to Circassia’s public cash offer
The total market value of a company. Circassia has reserved the right to waive these and other conditions for completion of the Offer.
The Board has taken into account a number of factors that the Board has considered relevant to the assessment of the Offer. Prjces figure represents last 12 months as of March 31, The information set out in this press release is announced in accordance with the Swedish Securities Markets Act and the Takeover Rules.
Circassia has not received any other non-public information that could reasonably be expected to affect the price of the Aerocrine share in connection with the review. Monitor lets you view up to of your favourite stocks at once and is completely free to use. Prics encompasses all issued stock – restricted and free trading.
Measuring airways inflammation helps doctors to diagnose, monitor and optimise therapy for people with inflammatory airway diseases. Aerocine does not hold any own shares in treasury.
Aerocrine Ab (GM) Stock Quote. ACNOF – Stock Price, News, Charts, Message Board, Trades
However, if the entire amount of the loan is prepaid, the penalty would be reduced by interest and milestone payments already paid. The higher the better. This press release does not constitute an extension into the United States or any other jurisdiction of the Offer mentioned in this press release.
Take the number of shares outstanding and multiple by current price.
This statement has been made in a Swedish and English version. Calculated by taking the current stock price and subtracting yesterday’s closing price. The Information was submitted for publication on May 15, at The acceptance period of the Offer adn expected to commence on May 19, and expire on June 11,subject to any extensions.
Aerocrine : The latest share price |
Aerocrine shares were listed on the Stockholm Stock Exchange on 15 June Additional shares in Aerocrine may be issued following this point in time as a result of exercise of outstanding personnel stock options and warrants in Aerocrine, and any such additional shares shall be included in the Offer.
Circassia is offering SEK 2. Based on the above, the Board unanimously recommends the Aerocrine shareholders to accept the Offer. Disputes arising from this statement shall be settled exclusively by Swedish courts.
Aerocrine AB is a medical technology company focused on pricfs improved anr and care of patients with inflammatory airway diseases.